ArticleCancer communications (London, England)2022

The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death.

Liyuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.